tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

EPIX Stock Latest News

ESSA Pharma Inc. Explores Strategic Options Amid Losses
Company AnnouncementsESSA Pharma Inc. Explores Strategic Options Amid Losses
9d ago
EPIX
ESSA Pharma Reports Q1 Loss, Explores Strategic Options
PremiumCompany Announcements
ESSA Pharma Reports Q1 Loss, Explores Strategic Options
11d ago
EPI
EPIX
Essa Pharma reports Q4 EPS (19c) vs. (14c) last year
PremiumThe Fly
Essa Pharma reports Q4 EPS (19c) vs. (14c) last year
11d ago
EPIX
ESSA Pharma Inc. (EPIX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
ESSA Pharma Inc. (EPIX) Q1 Earnings Cheat Sheet
18d ago
EPIX
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky LLP Before March 25, 2025 to Discuss Your Rights – EPIX
PremiumClass Action
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky LLP Before March 25, 2025 to Discuss Your Rights – EPIX
25d ago
EPIX
ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability
PremiumCompany AnnouncementsESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability
2M ago
EPIX
ESSA Pharma Inc. Reports Strategic Shift Amid Losses
Premium
Company Announcements
ESSA Pharma Inc. Reports Strategic Shift Amid Losses
2M ago
EPIX
Essa Pharma reports Q4 EPS (14c), consensus (27c)
Premium
The Fly
Essa Pharma reports Q4 EPS (14c), consensus (27c)
2M ago
EPIX
EPIX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EPIX Earnings this Week: How Will it Perform?
3M ago
EPIX
ESSA Pharma Introduces New Executive Severance Plan
PremiumCompany Announcements
ESSA Pharma Introduces New Executive Severance Plan
3M ago
8K
EPIX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
NVO
VIR
Essa Pharma downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Essa Pharma downgraded to Neutral from Overweight at Piper Sandler
4M ago
EPIX
Essa Pharma downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyEssa Pharma downgraded to Perform from Outperform at Oppenheimer
4M ago
EPIX
Essa Pharma downgraded to Hold from Buy at Jefferies
Premium
The Fly
Essa Pharma downgraded to Hold from Buy at Jefferies
4M ago
EPIX
Essa Pharma downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Essa Pharma downgraded to Hold from Buy at JonesResearch
4M ago
EPIX
Essa Pharma terminates Phase 2 study of masofaniten combo in mCRPC
PremiumThe Fly
Essa Pharma terminates Phase 2 study of masofaniten combo in mCRPC
4M ago
EPIX
Essa Pharma presents updated updated Phase 1/2 masofaniten data at ESMO
PremiumThe Fly
Essa Pharma presents updated updated Phase 1/2 masofaniten data at ESMO
5M ago
EPIX
PremiumCompany Announcements
ESSA Pharma Advances Prostate Cancer Clinical Trials
7M ago
EPI
EPIX
Essa Pharma reports Q3 EPS (16c), consensus (25c)
PremiumThe Fly
Essa Pharma reports Q3 EPS (16c), consensus (25c)
7M ago
EPIX
ESSA Pharma’s Promising Prostate Cancer Trial Updates
PremiumCompany AnnouncementsESSA Pharma’s Promising Prostate Cancer Trial Updates
9M ago
EPI
EPIX
Essa Pharma reports Q2 EPS (20c), consensus (19c)
Premium
The Fly
Essa Pharma reports Q2 EPS (20c), consensus (19c)
9M ago
EPIX
Premium
Company Announcements
ESSA Pharma Shareholders Show Strong Support
12M ago
EPI
EPIX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >